Clinical Trial Update: LCP-Tacro vs. Azathioprine for the Treatment of Autoimmune Hepatitis [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing LCP-Tacro to azathioprine for autoimmune hepatitis was terminated; results were posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Hepatitis

Drugs mentioned

• Azathioprine (azathioprine)
• LCP-Tacro (tacrolimus)

Snippet

Sponsor: Veloxis Pharmaceuticals | Conditions: Autoimmune Hepatitis | Phase 2 | Status: TERMINATED | Results posted: 2020-03-06